Cardiovascular adverse events following treatment with BTK inhibitors in CLL & MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:21 1 year ago 209 Далее Скачать
BTK inhibitor-associated adverse events in patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:18 2 years ago 76 Далее Скачать
Pericardial adverse events associated with BTKis in CLL: insights from two landmark trials VJHemOnc – Video Journal of Hematology & HemOnc 1:12 2 months ago 40 Далее Скачать
Outcomes of patients with CLL discontinuing BTK inhibitors due to adverse effects VJHemOnc – Video Journal of Hematology & HemOnc 1:12 3 days ago 43 Далее Скачать
Adverse events associated with BTK inhibitor therapy in NHL VJHemOnc – Video Journal of Hematology & HemOnc 1:53 3 years ago 128 Далее Скачать
Addressing cardiovascular AEs associated with BTKi treatment in patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:57 1 year ago 105 Далее Скачать
Are BTK inhibitors a suitable treatment option for CLL with cardiovascular comorbidities? VJHemOnc – Video Journal of Hematology & HemOnc 2:15 6 months ago 135 Далее Скачать
Adverse Events Differ Among BTK Inhibitors in CLL Targeted Oncology 1:04 4 years ago 125 Далее Скачать
Identifying patients with CLL at a high risk of developing cardiotoxicity with BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 3:37 1 year ago 215 Далее Скачать
Sequencing of BTK inhibitors in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:24 1 year ago 199 Далее Скачать
Cardiac toxicities associated with BTK inhibitor treatment VJHemOnc – Video Journal of Hematology & HemOnc 1:55 3 years ago 75 Далее Скачать
The current role of continuous BTK inhibitors in CLL treatment: benefits and drawbacks VJHemOnc – Video Journal of Hematology & HemOnc 3:35 1 year ago 333 Далее Скачать
Understanding Cardiotoxicity Risk with BTK Inhibitors in Hematologic Cancers: Muhammad Salman Faisal Oncology Data Advisor 3:17 6 months ago 28 Далее Скачать
New Standards for CLL Care With BTK Inhibitors PeerView Oncology 1:36:53 3 years ago 406 Далее Скачать
Treatment options for patients with CLL after failure of covalent BTK inhibitors and venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 1:11 1 year ago 68 Далее Скачать
Outcomes of CLL patients following treatment with a covalent BTK and BCL2 inhibitor VJHemOnc – Video Journal of Hematology & HemOnc 1:19 2 years ago 102 Далее Скачать
Factors Identified for Risk of Second Cancer in CLL Following BTK Treatment Targeted Oncology 0:55 5 years ago 114 Далее Скачать
Management of BTK class driven adverse events VJHemOnc – Video Journal of Hematology & HemOnc 4:22 3 years ago 69 Далее Скачать
Updates for Pharmacists: Utilizing BTK Inhibitors for the Treatment of CLL Medscape 33:15 6 months ago 2 Далее Скачать
